Preview

Артериальная гипертензия

Расширенный поиск

СОСУДИСТЫЕ КОГНИТИВНЫЕ НАРУШЕНИЯ: ВОЗМОЖНЫЕ МЕХАНИЗМЫ РАЗВИТИЯ

https://doi.org/10.18705/1607-419X-2013-19-4-326-333

Полный текст:

Аннотация

Распространенность сосудистых когнитивных нарушений возрастает по мере старения населения. Учитывая растущее медицинское, социальное и экономическое значение сосудистых когнитивных нарушений, их профилактика и лечение являются важными приоритетами в настоящее время. Выявление механизмов развития сосудистых когнитивных нарушений позволит целенаправленно проводить первичную и вторичную профилактику, а также осуществлять своевременную терапию.

Об авторе

И. Б. Зуева
Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова, Санкт-Петербург
Россия

Кандидат медицинских наук, заведующая кардиологическим отделением № 1 для больных инфарктом миокарда ФГБУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова» Минздрава России.

Контактная информация: ФГБУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова» Министер-ства здравоохранения Российской Федерации, ул. Аккуратова, д. 2, Санкт-Петербург, Россия, 197341. Тел. 8 (812) 702–68–11.  E-mail: iravit@yandex.ru (Зуева Ирина Борисовна).



Список литературы

1. Lobo A., Launer L.J., Fratiglioni L. et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group // Neurology. — 2000. — Vol. 54, № 11, Suppl. 5. — P. 4–9.

2. Wahlund L.E.T., Gauthier S. Vascular cognitive impairment in clinical practice // Cambridge, UK: Cambridge University Press. — 2009. — 254 p.

3. He W., Sengupta M., Velkoff V.A., DeBarros K.A. U.S. Census Bureau, Current Population Reports, P23–209, 65+ in the United States: 2005 // U.S. Government Printing Ofice, Washington, DC. — 2005. — 243 p.

4. Ukraintseva S., Sloan F., Arbeev K., Yashin A. Increasing rates of dementia at time of declining mortality from stroke // Stroke. — 2006. — Vol. 37, № 5. — P. 1155–1159.

5. Hachinski V.C., Bowler J.V. Vascular dementia // Neurology. — 1993. — Vol. 43, № 10. — P. 2159–2160.

6. Bowler J.V., Steenhuis R., Hachinski V. Conceptual background to vascular cognitive impairment // Alzheimer Dis. Assoc. Disord. — 1999. — Vol. 13, Suppl. 3. — P. 30–37.

7. O’Brien J.T., Erkinjuntti T., Reisberg B. et al. Vascular cognitive impairment // Lancet Neurol. — 2003. — Vol. 2, № 2. — P. 89–98.

8. Moorhouse P., Rockwood K. Vascular cognitive impairment: current concepts and clinical developments // Lancet Neurol. — 2008. — Vol. 7, № 3. — P. 246–255.

9. Rockwood K., Brown M., Merry H., Sketris I., Fisk J. Societal costs of vascular cognitive impairment in older adults // Stroke. — 2002. — Vol. 33, № 6. — P. 1605–1609.

10. Sicras A., Rejas J., Arco S. et al. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer’s dementia in a population setting // Dement. Geriatr. Cogn. Disord. — 2005. — Vol. 19, № 5–6. — P. 305–315.

11. Hill J., Fillit H., Shah S.N., Valle M.C., Futterman R. Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population // J. Alzheimers Dis. — 2005. — Vol. 8, № 1. — P. 43–50.

12. Boyle P.A., Cahn-Weiner D. Assessment and prediction of functional impairment in vascular dementia // Expert Rev. Neurother. — 2004. — Vol. 4, № 1. — P. 109–114.

13. Nys G.M., Zandvoort M.J., Worp H.B. et al. Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke // J. Neurol. Sci. — 2006. — Vol. 247, № 2. — P. 149–156.

14. Langa K.M., Foster N.L., Larson E.B. Mixed dementia: emerging concepts and therapeutic implications // J. Am. Med. Assoc. — 2004. — Vol. 292, № 23. — P. 2901–2908.

15. Jin Y.P., Legge S., Ostbye T., Feightner J.W., Hachinski V. The reciprocal risks of stroke and cognitive impairment in an elderly population // Alzheimers Dement. — 2006. — Vol. 2, № 3. — P. 171–178.

16. Knopman D.S., Roberts R.O., Geda Y.E. et al. Association of prior stroke with cognitive function and cognitive impairment: a population-based study // Arch. Neurol. — 2009. — Vol. 66, № 5. — P. 614–619.

17. Tatemichi T.K., Desmond D.W., Paik M. et al. Clinical determinants of dementia related to stroke // Ann. Neurol. — 1993. — Vol. 33, № 6. — P. 568–575.

18. Desmond D.W., Moroney J.T., Sano M., Stern Y. Incidence of dementia after ischemic stroke: results of a longitudinal study // Stroke. — 2002. — Vol. 33, № 9. — P. 2254–2260.

19. Desmond D.W., Moroney J.T., Paik M.C. et al. Frequency and clinical determinants of dementia after ischemic stroke // Neurology. — 2000. — Vol. 54, № 5. — P. 1124–1131.

20. Snowdon D.A., Greiner L.H., Mortimer J.A. et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study // J. Am. Med. Assoc. — 1997. — Vol. 277, № 10. —P. 813–817.

21. Esiri M.M., Nagy Z., Smith M.Z., Barnetson L., Smith A.D. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer’s disease // Lancet. — 1999. — Vol. 354, № 9182. — P. 919–920.

22. Schneider J.A., Arvanitakis Z., Bang W., Bennett D.A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons // Neurology. — 2007. — Vol. 69, № 24. — P. 2197–2204.

23. Skoog I., Nilsson L., Palmertz B. et al. A population-based study of dementia in 85-year-olds // N. Engl. J. Med. — 1993. — Vol. 328, № 3. — P. 153–158.

24. Ahtiluoto S., Polvikoski T., Peltonen M. et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study // Neurology. — 2010. — Vol. 75, № 13. —P. 1195–1202.

25. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers // Neurology. — 1992. — Vol. 42, № 3, Pt. 1. — P. 473–480.

26. Roman G.C., Tatemichi T.K., Erkinjuntti T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop // Neurology. — 1993. — Vol. 43, № 2. — P. 250–260.

27. Diagnostic and statistical manual of mental disorders. — 4. — Washington, DC: APA Press., 1994.

28. The ICD-10 classiication of mental and behavioral disorders. Clinical descriptions and diagnostic guidelines. — Switzer-land: WHO., 1992. — 267 p.

29. The ICD-10 classification of mental and behavioral disorders: diagnostic criteria for researchа. — Geneva, 1993. — 263 p.

30. Яхно Н.Н., Захаров В.В. Сосудистые когнитивные расстройства // Рос. мед. журн. — 2005. — Т. 13., № 12. — C. 789–793 / Yakhno N.N., Zakharov V.V. Vascular cognitive disorders // Russian Medical Journal [Rossiyskiy Meditsinskiy Zhurnal]. — 2005. — Vol. 13, № 12. — P. 789–793 [Russian].

31. Levine D.A., Langa K.M. Vascular cognitive impairment: disease mechanisms and therapeutic implication // Neurotherapeutics. — 2011. — Vol. 8, № 3. — P. 361–373.

32. O’Donnell M.J., Xavier D., Liu L. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study // Lancet. — 2010. — Vol. 376, № 9735. — P. 112–123.

33. Yoshitake T., Kiyohara Y., Kato I. et al. Incidence and risk factors of vascular dementia and Alzheimer’s disease in a deined elderly Japanese population: the Hisayama Study // Neurology. — 1995. — Vol. 45, № 6. — P. 1161–1168.

34. Kuller L.H., Lopez O.L., Jagust W.J. et al. Determinants of vascular dementia in the Cardiovascular Health Cognition Study // Neurology. — 2005. — Vol. 64, № 9. — P. 1548–1552.

35. Solomon A., Kivipelto M., Wolozin B. et al. Midlife serum cholesterol and increased risk of Alzheimer’s and vascular dementia three decades later // Dement. Geriatr. Cogn. Disord. — 2009. — Vol. 28, № 1. — P. 75–80.

36. Luchsinger J.A., Tang M.X., Stern Y., Shea S., Mayeux R. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort // Am. J. Epidemiol. — 2001. — Vol. 154, № 7. — P. 635–641.

37. Whitmer R.A., Gunderson E.P., Quesenberry C.P., Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia // Curr. Alzheimer Res. — 2007. — Vol. 4, № 2. — P. 103–109.

38. Ravaglia G., Forti P., Lucicesare A. et al. Physical activity and dementia risk in the elderly: indings from a prospective Italian study // Neurology. — 2008. — Vol. 70, № 19, Pt. 2. — P. 1786–1794.

39. Зуева И.Б., Ванаева К.И., Санец Е.Л. и др. Взаимосвязь факторов сердечно-сосудистого риска с когнитивными функциями у пациентов среднего возраста // Артериальная гипертензия. — 2011. — Т. 17, № 5. — С. 432–440. / Zueva I.B., Vanaeva K.I., Sanez E.L. et al. Association of cognitive function

40. with cardiovascular risk factors in middle age individuals // Arterial Hypertension [Arterialnaya Gipertenziya]. — 2011. — Vol. 17, № 5. — P. 432–440 [Russian].

41. Schiffrin E.L. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment // Am. J. Hypertens. — 2004. — Vol. 17, № 12, Pt. 1. — P. 1192–1200.

42. Izzard A.S., Rizzoni D., Agabiti-Rosei E., Heagerty A.M. Small artery structure and hypertension: adaptive changes and target organ damage // J. Hypertens. — 2005. — Vol. 23, № 2. — P. 247–250.

43. Intengan H.D., Thibault G., Li J.S., Schiffrin E.L. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor

44. antagonism and converting enzyme inhibition // Circulation. — 1999. — Vol. 100, № 22. — P. 2267–2275.

45. Antonios T.F.T., Singer D.R.J., Markandu N.D. Structural skin capillary rarefaction in essential hypertension // Hypertension. — 1999. — Vol. 33. — P. 998–1001.

46. Levy B.I., Ambrosio G., Pries A.R., Struijker-Boudier H.A. Microcirculation in hypertension — a new target for treatment? // Circulation. — 2001. — Vol. 104, № 6. — P. 735–740.

47. Le Noble F.A., Stassen F.R., Hacking W.J., Struijker-Boudier H.A. Angiogenesis and hypertension // J. Hypertens. — 1998. — Vol. 16, № 11. — P. 1563–1572.

48. Feihl F., Liaudet L., Waeber B., Levt B.I. Hypertension. A disease of the microcirculation? // Hypertension. — 2006. — Vol. 48, № 6. — P. 1–7.

49. De Leeuw F.E., de Groot J.C., Oudkerk M. et al. Hypertension and cerebral white matter lesions in a prospective cohort study // Brain. — 2002. — Vol. 125, № 4. — P. 765–772.

50. Casserly I., Topol E. Convergence of atherosclerosis and Alzheimer’s disease: inlammation, cholesterol, and misfolded proteins // Lancet. — 2004. — Vol. 363, № 9415. — P. 1139–1146.

51. Iadecola C., Park L., Capone C. Threats to the mind: aging, amyloid, and hypertension. — Stroke. — 2009. — Vol. 40, № 3, suppl. — P. 40–44.

52. Iadecola C., Gorelick P.B. Converging pathogenic mechanisms in vascular and neurodegenerative dementia // Stroke. — 2003. — Vol. 34, № 2. — P. 335–337.

53. Middleton L.E., Yaffe K. Promising strategies for the prevention of dementia // Arch. Neurol. — 2009. — Vol. 66, № 10. — P. 1210–1215.

54. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged // Arch. Neurol. — 2009. — Vol. 66, № 3. — P. 300–305.

55. Wardlaw J.M., Sandercock P.A., Dennis M.S. et al. Isbreakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? // Stroke. — 2003. — Vol. 34, № 3. — P. 806–812.

56. Murray A.M. The brain and the kidney connection: а model of accelerated vascular cognitive impairment // Neurology. — 2009. — Vol. 73, № 12. — P. 916–917.

57. Puccio D., Novo G., Baiamonte V. et al. Atrial ibrillation and mild cognitive impairment: what correlation? // Minerva Cardioangiol. — 2009. — Vol. 57, № 2. — P. 143–150.

58. Oijen M., Witteman J.C., Hofman A., Koudstaal P.J., Breteler M.M. Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia // Stroke. — 2005. —Vol. 36, № 12. — P. 2637–2641.

59. Gallacher J., Bayer A., Lowe G. et al. Is sticky blood badfor the brain?: Hemostatic and inlammatory systems and dementia in the Caerphilly Prospective Study // Arterioscler. Thromb. Vasc. Biol. — 2010. — Vol. 30, № 3. — P. 599–604.

60. Ivan C.S., Seshadri S., Beiser A. et al. Dementia after stroke: the Framingham Study // Stroke. — 2004. — Vol. 35, № 6. — P. 1264–1268.

61. Zuliani G., Guerra G., Ranzini M. et al. High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia // Int. J. Geriatr. Psychiatry. — 2007. — Vol. 22, № 4. — P. 305–311.

62. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease trends // Neuroscience. — 1994. — Vol. 17, № 12. — P. 525–530.

63. Strittmatter W.J., Saunders A.M., Schmechel D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease // Proc. Natl. Acad. Sci. USA. — 1993. — Vol. 90, № 5. — P. 1977–1981.

64. Sing C.F., Davington J. Role of apolipoprotein E genetic polymorphism in determining normal plasma lipid and lipoprotein variation // Am. J. Hum. Gen. — 1985. — Vol. 37, № 2. —Р. 268–285.

65. Davignon J., Gregg R.E., Sing S.F. Apolipoprotein E polymorphism and atherosclerosis // Arteriosclerosis. — 1988. — Vol. 8, № 1. — P. 1–21.

66. Terry J.G., Howard G., Mercuri M., Bond M.G., Crouse J.R. 3rd. Apolipoprotein E polymorphism is associated with segment-speciic extracranial carotid artery intima-media thickening // Stroke. — 1996. — Vol. 27, № 10. — P. 155–175.

67. Cattin L., Fisicaro M., Tonizzo M. еt al. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis deined by ultrasonography in asymptomatic adults // Arterioscl. Thromb. Vasc. Biol. — 1997. — Vol. 17, № 1. — P. 91–97.

68. Vauhkonen I., Nisknen L., Ryynanen M. Divergent association of apolipoprotein E polymorphism with vascular disease in patients with NIDDM and control subjects // Diabet. Med. — 1997. — Vol. 14, № 9. — P. 748–756.

69. Hanon O., Girerd X., Luong V., Jeunemaitre X., Laurent S., Safar M.E. Association between the apolipoprotein E polymorphism and arterial wall thickness in asymptomatic adults // J. Hyperten. — 2000. — Vol. 18, № 4. — P. 431–436.

70. Hillen T., Niecza R., Munzmerg H. et al. Carotid atherosclerosis, vascular risk proile and mortality in a population-based sample of functionally healthy elderly subjects: the Berlin Ageing Study // J. Intern. Med. — 2000. — Vol. 247, № 6. — P. 679–688.

71. Baum L., Lam L.C., Kwok T. et al. Apolipoprotein E epsilon4 allele is associated with vascular dementia // Dement. Geriatr. Cogn. Disord. — 2006. — Vol. 22, № 4. — P. 301–305.

72. Kuller L.H., Lopez O.L., Newman A. et al. Risk factors for dementia in the cardiovascular health cognition study // Neuroepidemiol. — 2003. — Vol. 22, № 1. — P. 13–22.

73. Elkins J.S., Johnston C.S., Elad Ziv E. et al. Methylenetetrahydrofolate Reductase C677T Polymorphism and Cognitive Function in Older // Am. J. Epidemiol. — 2007. — Vol. 166, № 6. — P. 672–678.

74. Khandanpour N., Willis G., Meyer F.J. et al. Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis // J. Vasc. Surg. — 2009. — Vol. 49, № 3. — P. 711–718.

75. Clarke R., Smith A.D., Jobst K.A., Refsum H., Sutton L., Ueland P.M. Folate, vitamin B12, and serum total homocysteine levels in conirmed Alzheimer disease // Arch. Neurol. — 1998. — Vol. 55, № 11. — P. 1449–1455.

76. McIlroy S.P., Dynan K.B., Lawson J.T., Patterson C.C., Passmore A.P. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland // Stroke. — 2002. — Vol. 33, № 10. — P. 2351–2356.

77. Datta S., Pal S. K., Mazumdar H., Bhandari B., Bhattacherjee S., Pandit S. Homocysteine and cerebrovascular accidents // J. Indian Med. Assoc. — 2009. — Vol. 107, № 6. — P. 345–346.

78. Seshadri S., Beiser A., Selhub J. et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease // N. Engl. J. Med. — 2002. — Vol. 346, № 7. — P. 476–483.

79. Tsai S.J., Hong C.J., Yeh H.L. et al. Heterozygote аdvantage of the MTHFR C677T рolymorphism on speciic cognitive performance in elderly chinese males without dementia // Dement. Geriatr. Cogn. Disord. — 2011. — Vol. 32, № 3. — P. 159–163.

80. Margues G.M.D., Krieger J.E., Casarini D.E. Angiotensinconverting enzyme: a possible genetic marker // Hypertension. — 2002. — Vol. 20, suppl. 4. — 263 p.

81. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V. et al. Molecular basis of human hypertension: role of angiotensinogen // Cell. — 1992. — Vol. 71, № 1. — P. 169–180.

82. Liu H., Liu M., Li W. Association of ACE I/D gene polymorphism with vascular dementia: a meta-analysis // J. Geriatr. Psych. Neurol. — 2009. — Vol. 22, № 1. — P. 10–22.

83. Liu M.E., Tsai S.J., Lu T. No association of angiotensin I converting enzyme I/D polymorphism with domain-speciic cognitive function in aged men without dementia // Neuromol. Med. — 2011. — Vol. 13, № 3. — P. 212–216.

84. Zhang Z., Deng L., Bai F. Alteration of resting brain function by genetic variation in angiotensin converting enzyme in amnestic-type mild cognitive impairment of Chinese Han // Behav. Brain Res. — 2010. — Vol. 208, № 2. — P. 619–625.

85. Zhang Z., Deng L., Bai F. ACE I/D polymorphism affects cognitive function and gray-matter volume in amnestic mild cognitive impairment // Behav. Brain Res. — 2011. — Vol. 218, № 1. — P. 114–120.

86. Bai F., Zhang Z., Watson D.R. et al. Abnormal functional connectivity of hippocampus during episodic memory retrieval processing network in amnestic mild cognitive impairment // Biol. Psych. — 2009. — Vol. 65, № 11. — P. 951–958.

87. Groop L. Genetics of the metabolic syndrome // Br. J. Nutr. — 2000. — Vol. 83, suppl. 1. — P. S39–S84.

88. Sierra C., Gomez-Angelats E., Poch E. Renin-angiotensin system genetic polymorphisms and cerebral white matter lesions in essential hypertension // Hypertension. — 2002. — Vol. 39, № 2,

89. Pt. 2. — P. 343–347.

90. Mykkanen L., Kuusisto J., Pyorala K., Laakso M. Cardiovascular disease risk factors as predictors of type 2 (noninsulin-dependent) diabetes mellitus in elderly subjects // Diabetologia. — 1993. — Vol. 36, № 6. — P. 553–559.

91. Nicholls M.G., Richards A.M., Agarwal M. The importance of the renin-angiotensin system in cardiovascular disease // J. Hum. Hypertens. — 1998. — Vol. 12, № 5. — P. 295–299.

92. Hsieh M.C., Lin S.R., Hsieh T.J. Increased frequency of angiotensin-converting enzyme D/D genotype in patients with type 2 diabetes in Taiwan // Nephrol. Dial. Transplant. — 2000. — Vol. 15, № 7. — P. 1008–1013.

93. Cassis L.A., Police S.B., Yiannikouris F., Thatcher S.E. Local adipose tissue renin-angiotensin system // Curr. Hypertens. Rep. — 2008. — Vol. 10, № 2. — P. 93–98.

94. Van Swieten J.C., Geyskes G.G., Derix M.M.A. Hypertension in the elderly is associated with white matter lesions and cognitive decline // Ann. Neurol. — 1991. — Vol. 30, № 6. — P. 825–830.

95. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene accounting for half the variance of serum enzyme levels // J. Clin. Invest. — 1990. — Vol. 86, № 4. — P. 1343–1346.

96. Staessen J.A., Ginocchio G., Petrov V. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk // J. Hyperten. — 1997. — Vol. 15, № 12, Pt. 2. — P. 1579–1592.

97. Sharma P. Meta-analysis of the ACE gene in ischemic stroke // J. Neurol. Neurosurg. Psych. — 1998. — Vol. 64. — P. 227–230.

98. Kario K., Kanai N., Saito K., Nago N., Matsuo T., Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives // Circulation. — 1996. — Vol. 93, № 9. — P. 1630–1633.

99. Niu T., Yang J., Wang B. et al. Angiotensinogen genepolymorphisms M235T/T174 M: no excess transmission to hypertensive Chinese // Hypertension. — 1999. — Vol. 33, № 2. — P. 698–702.

100. Taittonen L., Kontula K., Kainulainen K. Angiotensinogen converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension,and childhood blood pressure // Am. J. Hypertens. — 1999. — Vol. 12. — P. 858–866.

101. Saab Y.B., Gard P.R., Overall A.D. The association of hypertension with renin-angiotensin system gene polymorphisms in the Lebanese population // J. Renin-Angiotensin-Aldosterone Syst. — 2011. — Vol. 12, № 4. — P. 588–594.

102. Lenkei Z., Palkovits M., Corvol P. et al. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: A functional neuroanatomical review // Frontiers Neuroendocrinol. — 1997. — Vol. 18, № 9, Pt. 1. — P. 383–439.

103. Hajjar I., Kritchevsky S., Newman A.B. Renin angiotensin system gene polymorphisms modify angiotensin converting enzyme (ACE) inhibitors’ effect on cognitive function: the Health, Aging and Body Composition Study // J. Am. Geriatr. Society. — 2010. — Vol. 58, № 6. — P. 1035–1042.


Для цитирования:


Зуева И.Б. СОСУДИСТЫЕ КОГНИТИВНЫЕ НАРУШЕНИЯ: ВОЗМОЖНЫЕ МЕХАНИЗМЫ РАЗВИТИЯ. Артериальная гипертензия. 2013;19(4):326-333. https://doi.org/10.18705/1607-419X-2013-19-4-326-333

For citation:


Zueva I.V. VASCULAR COGNITIVE IMPAIRMENT: POSSIBLE MECHANISMS OF DEVELOPMENT. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2013;19(4):326-333. (In Russ.) https://doi.org/10.18705/1607-419X-2013-19-4-326-333

Просмотров: 203


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)